Vasopressin, Volume 113 in the Vitamins and Hormones series, highlights new advances in the field, with this new volume presenting updates on timely topics, including Diabetes Insipidus in Pregnancy, Vasopressin Inactivation: Role of Insulin-Regulated Aminopeptidase, Vasotocin and the Origins of the Vasopressin/Oxytocin Receptor Gene Family, Vasopressin V2 Receptor Ligand Recognition, Development and Therapeutic Potential of Vasopressin Synthetic Analog [V4Q5]dDAVP as a Novel Anticancer Agent, Cellular Junctions and Vasopressin, Vasopressin Actions in the Kidney Renin Angiotensin System and its Role in Hypertension and Renal Disease, Oxytocin/Vasopressin-Like Neuropeptide Signaling in Insects, and much more.
1. Cover image - p. page_i 2. Title page - p. page_i 3. Table of Contents - p. page_i 4. Copyright - p. page_iv 5. Former Editors - p. page_v 6. Contributors - p. page_xi 7. Preface - p. page_xv 8. Chapter One: Vasotocin and the origins of the vasopressin/oxytocin receptor gene family - p. page_xvi 9. Chapter Two: Oxytocin/vasopressin-like neuropeptide signaling in insects - p. page_27 10. Chapter Three: Amyloid-like aggregation of provasopressin - p. page_53 11. Chapter Four: V2 vasopressin receptor mutations - p. page_77 12. Chapter Five: Vasopressin inactivation: Role of insulin-regulated aminopeptidase - p. page_99 13. Chapter Six: Molecular aspects of aquaporins - p. page_128 14. Chapter Seven: The vasotocinergic system and its role in the regulation of stress in birds - p. page_181 15. Chapter Eight: Vasopressin actions in the kidney renin angiotensin system and its role in hypertension and renal disease - p. page_216 16. Chapter Nine: Vasopressin receptor subtypes and renal sodium transport - p. page_238 17. Chapter Ten: Development and therapeutic potential of vasopressin synthetic analog [V4Q5]dDAVP as a novel anticancer agent - p. page_258 18. Chapter Eleven: Vasopressin and vasopressin receptors in brain edema - p. page_289
Vasopressin, Volume 113 in the Vitamins and Hormones series, highlights new advances in the field, with this new volume presenting updates on timely topics, including Diabetes Insipidus in Pregnancy, Vasopressin Inactivation: Role of Insulin-Regulated Aminopeptidase, Vasotocin and the Origins of the Vasopressin/Oxytocin Receptor Gene Family, Vasopressin V2 Receptor Ligand Recognition, Development and Therapeutic Potential of Vasopressin Synthetic Analog [V4Q5]dDAVP as a Novel Anticancer Agent, Cellular Junctions and Vasopressin, Vasopressin Actions in the Kidney Renin Angiotensin System and its Role in Hypertension and Renal Disease, Oxytocin/Vasopressin-Like Neuropeptide Signaling in Insects, and much more.
1. Cover image - p. page_i 2. Title page - p. page_i 3. Table of Contents - p. page_i 4. Copyright - p. page_iv 5. Former Editors - p. page_v 6. Contributors - p. page_xi 7. Preface - p. page_xv 8. Chapter One: Vasotocin and the origins of the vasopressin/oxytocin receptor gene family - p. page_xvi 9. Chapter Two: Oxytocin/vasopressin-like neuropeptide signaling in insects - p. page_27 10. Chapter Three: Amyloid-like aggregation of provasopressin - p. page_53 11. Chapter Four: V2 vasopressin receptor mutations - p. page_77 12. Chapter Five: Vasopressin inactivation: Role of insulin-regulated aminopeptidase - p. page_99 13. Chapter Six: Molecular aspects of aquaporins - p. page_128 14. Chapter Seven: The vasotocinergic system and its role in the regulation of stress in birds - p. page_181 15. Chapter Eight: Vasopressin actions in the kidney renin angiotensin system and its role in hypertension and renal disease - p. page_216 16. Chapter Nine: Vasopressin receptor subtypes and renal sodium transport - p. page_238 17. Chapter Ten: Development and therapeutic potential of vasopressin synthetic analog [V4Q5]dDAVP as a novel anticancer agent - p. page_258 18. Chapter Eleven: Vasopressin and vasopressin receptors in brain edema - p. page_289
